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Technical and technological innovations have spearheaded the expansion of the indications for 
the use of endoscopic endonasal approaches to extirpate malignancies of the sinonasal tract and 
adjacent skull base.
Objective: Critical review of the available literature regarding the use of endoscopic endonasal 
approaches including indications, limitations, surgical techniques, oncologic outcome, and quality 
of life.
Method: Various endoscopic endonasal techniques are reviewed according to the origin and local 
extension of sinonasal and skull base malignancies including anterior cranial base, nasopharynx, 
clivus, and infratemporal fossa. In addition, the available literature is reviewed to assess outcomes.
Conclusion: Endoscopic endonasal approaches are an integral part of the armamentarium for the 
treatment of the sinonasal tract malignancies and skull base. In properly selected cases, it affords 
similar oncologic outcomes with lower morbidity than traditional open approaches. Nonetheless, 
these minimal access approaches should be considered a complement to well-established open 
approaches, which are still necessary in most advanced tumors.
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INTRODUCTION
Sinonasal carcinomas are uncommon malignan-
cies, representing approximately 0.2% of all cancers 
and 3% to 5% of cancers in upper aerodigestive tract1-3. 
In their early phase, these tumors commonly produce 
symptoms that are similar to those caused by inflam-
matory sinonasal disease: nasal airway obstruction, 
epistaxis, headache, facial pain, and nasal discharge. 
Lack of any significant symptom is also relatively com-
mon; thus, causing a delay in diagnosis and progression 
of the tumor to advanced stages. Optimal treatment 
remains undefined, however; surgery followed by 
postoperative radiotherapy or chemoradiotherapy is 
currently considered for the vast majority of patients 
with locally advanced disease.
Oncologic surgery implies an adequate resection 
(complete) of the tumor sparing normal structures. En 
bloc resection of sinonasal tumors, considered stan-
dard treatment for many years, flourished with the 
development of transfacial approaches (i.e. lateral rhi-
notomy, and midfacial degloving) and the combination 
of transcranial and transfacial approaches for tumors 
involving the skull base. Open approaches, however, 
are associated to postoperative morbidity that includes 
external scars, maxillofacial cosmetic defects due to 
ostectomies or translocation of the maxillofacial skel-
eton; and, more important, injury related to retraction 
of the brain. Alternative minimal invasive techniques 
have been progressively introduced to reduce or avoid 
these complications.
Over the past two decades, endoscopic endonasal 
techniques have been developed mainly based on an 
expanded fund of knowledge regarding endoscopic 
anatomy, and the development of novel surgical tech-
niques and technologies that have enabled the complete 
resection of malignancies (i.e. with negative margins). 
Endoscopic endonasal approaches to the skull base com-
prise two critical tenets, bilateral nasal access to allow for a 
two-surgeon-four-hand technique (i.e. bimanual dissection 
and dynamic movement of the endoscope) and custom-
ized removal of bone to create a wide surgical corridor 
that allows adequate visualization and instrumentation.
A significant advantage of the endoscopic endo-
nasal approaches is that they provide the most direct 
access to the ventral skull base while obviating the 
retraction and manipulation of critical neurovascular 
structures4-7. To facilitate their understanding and com-
munication among surgeons, the endoscopic endonasal 
approaches can be organized according to their ana-
tomical orientation into sagittal (median) and coronal 
planes. Approaches in the sagittal plane access the 
ventral skull base from the frontal sinus to the second 
cervical vertebra8; therefore, providing an endoscopic 
corridor for an oncologic resection the anterior cranial 
base, median nasopharynx, and clivus. Endoscopic 
approaches in the coronal plane expose lesions that 
extend laterally to the midline of the roof of the orbit 
(anterior coronal approaches), the floor of the middle 
cranial fossa (middle coronal approaches), and the 
jugular foramen (posterior coronal approaches)9.
Unfortunately, advances in the reconstruction 
after endoscopic endonasal approaches lagged signifi-
cantly behind advances in the approach and resection of 
tumors of the skull base. Reconstructive outcomes were 
variable until the adoption of the Hadad-Bassagaisteguy 
nasoseptal flap, which is a robust flap that can cover an 
area comprising from the posterior wall of the frontal 
sinus to the sellae turcica and from orbit to orbit10-12. 
Other alternative flaps were subsequently described, 
specifically used in patients in whom the nasoseptal 
flap is unavailable due to invasion of tumor or previous 
surgery13. Alternative pedicled flaps include turbinate 
flaps14-16, transpterygoid temporoparietal fascia flap17, 
transfrontal pericranial flap18,19, Oliver palatal flap20,21, 
lateral nasal wall flaps22,23.
In this manuscript, we will present our view of 
the current principles and techniques for the endo-
scopic endonasal resection of malignancies involving 
specific sites of the skull base. No surgical technique 
should be discussed in a vacuum, as its outcomes are 
highly dependent on an adequate selection of patients, 
thorough planning, precise surgical technique and use 
of adjunctive measures; therefore, we present a brief 
discussion of our preoperative and intraoperative prepa-
rations and management. In addition, we will present 
a critical appraisal of the available literature, as well as 
our experience.
PREOPERATIVE EVALUATION
Preoperative evaluation for patients undergo-
ing an endoscopic endonasal resection does not differ 
from that of other approaches. All patients undergo a 
complete examination of head and neck with emphasis 
on the sinonasal region, orbit, status of cervical lymph 
nodes, and basic neurologic function (especially cranial 
nerve status). In addition, sinonasal endoscopy provides 
a detailed assessment of the sinonasal tract and tumor 
characteristics, ascertaining any anatomical variation, 
absence of active infection, vascularity of the tumor 
and occasionally its site of origin.
Computed tomographic scan (CT) and mag-
netic resonance imaging (MRI) are complementary 
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investigations that evaluate the bony and soft tissue 
extensions of the tumor, including orbital, intracranial, 
perineural, and vascular extensions, and suggest its 
degree of vascularity; therefore, serving as preoperative 
surgical maps. For tumors that involve or are adjacent 
to critical neurovascular structures, we advocate a CT 
angiography (CTA) for surgical planning, and for im-
age fusion with MRI during intraoperative navigation.
It is critical to confirm the tumor histology before 
the definitive surgery. However, there are exceptional 
circumstances that justify a deviation from this axiom. 
Pathognomonic characteristics in the imaging of the 
tumor, patient comorbidities increasing the surgical 
risk (i.e. a second surgery maybe ill advised), and or-
ganizational or institution logistics may warrant special 
consideration to using intraoperative histological con-
firmation followed by definitive resection.
Inflammation and bleeding associated with a 
biopsy may alter the tumor appearance in the MRI; 
thus, we prefer completing the imaging first, whenever 
possible. In addition, a contrasted imaging may afford 
an estimate of the tumor vascularity, and cue the team 
to prepare for the possibility of significant bleeding. In 
general, large tumors that are easily visualized in the 
anterior nasal cavity may be biopsied with minor risk in 
the office setting. Other tumors are commonly biopsied 
in the operating room where an adequate volume of 
tissue can be sampled, and where bleeding and possible 
communication with cerebrospinal fluid (CSF) can be 
avoided or managed promptly and effectively.
A fused PET and CT scan is best to identify me-
tastasis in patients presenting with advanced disease, 
and those who present with tumors that are known 
to spread hematogenously (e.g. sarcomas, melanoma, 
and adenoid cystic carcinoma). Similarly, sarcomas and 
other high-grade malignancies with dural transgression 
warrant a cytological analysis of the cerebrospinal fluid 
(i.e., lumbar spinal puncture), and a MRI of the spine 
to rule out the presence of “drop metastasis”24.
SURGICAL SETUP
After orotracheal intubation, the endotracheal 
tube is fixed toward the left side and the patient is 
placed in a 3-pin head holder with the neck tilted 
slightly to the left and turned slightly to the right. In se-
lect cases, a “horseshoe” type head holder can be used; 
however, we prefer to pin the head in prolonged surger-
ies, those in which extensive drilling is anticipated and 
those in which the patient cannot be paralyzed due to 
the monitoring of cranial nerves (i.e. EMG monitoring).
The nose is decongested with topical 0.05% oxy-
metazoline or epinephrine 1/10,000-1/20,000. Povidone 
is applied to the perinasal and periumbilical regions (in 
the event that an autologous fat free graft is required 
for reconstruction). If the patient presents a high risk 
for internal carotid artery (ICA) injury, or if the surgeon 
anticipates the need for fascia lata free grafting, the 
thigh is also prepped. Broad-spectrum prophylactic 
perioperative antibiotics (third generation cephalosporin 
with cerebrospinal fluid penetration) are administered 
and continued through the second postoperative day 
(nasal packing may require an extended course of 
antibiotics).
Monitoring of the somatosensory evoked poten-
tials (SSEPs) identifies early signs of brain compromise 
due to ischemia, edema, contusion and hemorrhage; 
thus, we advocate its use when available. In addition, 
cranial nerve injuries may occur when resection of 
tumor extends into the retrobulbar orbit, superior orbital 
fissure, or cavernous sinus; therefore, monitoring with 
electromyography of the pertinent cranial nerve and 
muscle is indicated.
A 0° rod lens endoscope provides undistorted 
and adequate visualization of the surgical field and 
enables the use of straight instrumentation (its line of 
sight matches the geometry of the instruments). Con-
versely, angled lens endoscopes allow looking around 
the corner; however, they are more difficult to use due 
to their distorted view and because they require angled 
instruments to match their line of sight. Therefore, we 
prefer to use the 0° rod lens endoscope coupled to a 
high definition endoscopic camera and monitor for 
visualization during most of the surgery, maintaining a 
clean lens by manual irrigation.
ENDOSCOPIC ENDONASAL RESECTION
General Principles
As previously mentioned, the sinonasal tract is a 
somewhat silent region in the sense that symptoms are 
mild or absent until the tumor attains significant exten-
sion; therefore, most patients present with advanced 
carcinomas that often involves the cranial base or ex-
tends laterally to the infratemporal fossa. Endoscopic 
endonasal approach can address the target lesions via 
modular approaches anatomically oriented in the sagit-
tal plane or coronal plane. However, pure endoscopic 
endonasal approaches for malignant tumors are limited 
by paramedian critical neurovascular structures (i.e. 
orbit, optic nerve, ICA); thus, extension beyond these 
lateral boundaries constitute a contraindication for an 
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endoscopic endonasal approach (or indicate the need 
for a second external approach). Other similar contra-
indications include tumor extending laterally across the 
mid-orbital plane, invasion of the orbital soft tissues 
(i.e. requiring an orbital exenteration), involvement of 
anterior table or lateral recesses of the frontal sinus, 
the need to perform a total maxillectomy, or the need 
to remove skin due to tumor invasion. Furthermore, 
an active sinonasal bacterial or fungal infection contra-
indicates an elective endoscopic endonasal transdural 
approach; thus, it should be treated prior to surgery25,26.
Surgery aims toward a complete tumor extirpation 
with negative margins. However, opposed to traditional 
open approaches, endoscopic endonasal resection of 
a malignancy is rarely completed en bloc. This salient 
feature of endoscopic endonasal resection has been 
criticized by some; however, a similar dilemma has 
been previously faced with cancers in other regions of 
the head and neck including pharyngeal and laryngeal 
squamous cell carcinoma, and skin cancer (Moh’s sur-
gery). Select cancers in these areas are currently resected 
in a piecemeal or layered fashion without jeopardizing 
the outcomes. Similar findings have been reported for 
the resection of sinonasal malignancies with endoscopic 
endonasal surgery, suggesting that a piecemeal or layered 
resection does not compromise the oncologic resection27.
Endoscopic endonasal anterior cranial base resection
Indications and limitations
Sinonasal carcinomas (e.g. squamous cell carci-
noma, melanoma, basal cell carcinoma, adenoid cystic 
carcinoma, and mucoepidermoid carcinoma) are the 
most common malignancies to involve the anterior 
cranial base. In addition, several primary malignancies 
originate from olfactory epithelium and other neural 
tissue of the anterior cranial base (e.g. esthesioneu-
roblastomas, neuroendocrine carcinomas, sinonasal 
undifferentiated carcinomas and primitive neuroecto-
dermal tumors). Lymphoreticular tumors and sarcomas 
(e.g. lymphomas, plasmacytomas, chondrosarcomas, 
osteosarcomas, rhabdomyosarcomas, malignant heman-
giopericytomas, and malignant giant cell tumors) are 
also encountered, although less commonly. Many of 
these tumors are median lesions that can be addressed 
via an endoscopic endonasal approach. However, as 
previously mentioned, a pure endoscopic endonasal 
approach has important limitations. A traditional open 
or endoscopic-assisted craniofacial resection should 
be considered when the tumor extends beyond the 
boundaries that are amenable to an endoscopic resec-
tion. However, if the tumor is considered unresectable 
a pure endoscopic endonasal approach may play a 
palliative role to open the sinonasal airway, provide 
drainage to the paranasal sinuses, control hemorrhage 
or decompress the orbit, or other neural structures27.
Surgical technique (Figure 1)
Identification of the site of origin is important but 
may not by reliably established until surgery. This is 
true for the great majority of patients, who present with 
advanced, large tumors that occlude the nasal cavity. 
Therefore, surgery typically starts with a debulking of 
the tumor to define the site of origin, as well as its rela-
tionship with the skull base and other critical anatomy. 
The initial approach is usually performed through the 
nostril with predominant involvement of tumor; thus, 
facilitating its debulking. An ipsilateral middle turbinec-
tomy gains further space for instrumentation and allow 
a better assessment of the tumor. If the tumor involves 
Figure 1. A-C: Anterior skull base tumor involving the nasal cavity 
bilaterally; therefore, requiring a bilateral resection; D: Sequentially, a 
wide sphenoidotomy and nasoantral window are completed; E-F: A 
HBF is raised on the healthy side of the nasal septum and is stored in 
the nasopharynx; a bony posterior septectomy and Caicedo’s reverse 
flap follows. This allows communicating the posterior nasal cavities 
into a single chamber; G: Bilateral frontal sinusotomy (Draf Type III), 
followed by the drilling of the crista galli, help to establish the anterior 
resection margin; H: The anterior and posterior ethmoid arteries are 
coagulated and divided; I: Anterior cranial base bone is dissected off 
the dura including fovea ethmoidalis, cribriform plate, and crista galli; 
J-L: After complete bony removal, the dura is exposed and opened in 
the ‘inverted U’, starting the incisions at the lateral margins; M-N: The 
cerebral falx is incised in a ventro-caudal direction; O: The olfactory 
nerves are resected for margins and their stumps are cauterized; 
P-R: This allows the infero-posterior displacement and resection of 
any residual tumor and cribiform plate en bloc; S: Once margins are 
deemed free from tumor by histological analysis, the reconstruction is 
performed; T: A collagen matrix graft is inlaid and the HBF is onlaid. Rt. 
MT: Right middle turbinate; Lt. MT: Left middle turbinate; MS: Maxillary 
sinus; SS: Sphenoid sinus; HBF: Hadad-Bassagaisteguy nasoseptal 
flap; FS: Frontal sinus; AEA: Anterior ethmoidal artery; PEA: Posterior 
ethmoidal artery; CG: Crista galli; ON: Olfactory nerve; CM: Collagen 
matrix.
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the nasal cavity bilaterally, both middle turbinates are 
resected. A wide sphenoidotomy and nasoantral win-
dow allow the identification of the skull base (i.e. roof 
of the sphenoid sinus) and lamina papyracea.
A Hadad-Bassagaisteguy flap may be raised 
from the contralateral side and stored in the sphenoid, 
ipsilateral antrum, or left flat against its ipsilateral lateral 
nasal wall according to the need for exposure of each 
of sites. A subsequent posterior bony septectomy and 
Caicedo’s reverse flap (CRF)28,29 follows. We recommend 
histological analysis (negative margins) of the superior 
and posterior incisions (or any other pertinent area) 
of both flaps to avoid leaving persistent tumor, or 
seeding the tumor into new areas such as the columella. 
Resection of the nasal septum is tailored to the exten-
sion of the disease. Therefore, bilateral extension often 
mandates a large septectomy that precludes the harvest 
of the pedicle nasoseptal flap. Similarly, if the tumor has 
contralateral involvement of rostrum of the sphenoid or 
pterygopalatine fossa, these flaps will not be available 
and an alternative reconstruction should be planned.
Bilateral ethmoidectomies further expose the su-
perior aspect of the nasal cavity and the attachments of 
the turbinates and septum to the anterior cranial base. 
Resection of the superior turbinate while completing the 
posterior ethmoidectomy, exposes the spheno-ethmoid 
recess and natural ostium of the sphenoid sinus that may 
be enlarged to allow inspection of the sinus, enhance 
drainage, or remove tumor. The nasofrontal recess is 
identified and a Draf 2 (for a unilateral resection) or Draf 
3 (for a bilateral resection) is opened. These steps are re-
peated bilaterally according to the extension of the tumor.
Removal of the lamina papyracea offers an ad-
ditional margin and aids in the identification of the 
anterior and posterior (and in some patients a middle) 
ethmoidal neurovascular bundles. The remaining tis-
sue includes the tumor base, which is removed before 
drilling the bone of the anterior fossa floor. A frontal 
sinusotomy (unilateral Draf 2 or a Draf 3), followed 
by the drilling of the crista galli, help to establish the 
anterior resection margin.
The fovea ethmoidalis and cribriform plate are 
drilled thin and dissected off the dura bilaterally. If 
necessary due to tumor extension, the bone of the 
planum sphenoidale may be removed back to the level 
of the optic nerve foramina. The anterior and posterior 
ethmoid arteries are identified, coagulated with a bi-
polar electrocautery, and divided. After completing the 
bony removal, the dura is exposed and opened in the 
‘inverted U’ fashion, starting at the lateral margins to 
avoid injury of the median fronto-polar, fronto-orbital 
and parafalcine arteries. The cerebral falx is incised in a 
ventro-caudal direction under direct visualization. This 
allows infero-posterior displacement of the residual 
tumor and the dura en bloc. Using gentle suction as trac-
tion, and sharp dissection, all arachnoid adherences are 
freed and both olfactory bulbs are resected for margins. 
Great care is taken to preserve the fronto-polar arteries 
and the integrity of the frontal lobes.
The final defect frequently extends from orbit to 
orbit and from crista galli to planum sphenoidale. An 
important olfaction-sparing variation may be possible in 
patients with select unilateral tumors. In this technique 
the olfactory cleft as well as the middle and superior 
turbinates of the uninvolved side are preserved.
Reconstructive technique
Once adequate resection margins are confirmed 
by intraoperative histological analysis, and hemostasis 
is corroborated, we proceed with the reconstruction 
of the defect using an inlay sheet of collagen matrix 
or fascia lata. Then, the Hadad-Bassagaisteguy flap is 
retrieved and positioned over the defect. Occasionally, 
a fat graft is inserted prior to positioning the flap; this 
measure obliterates dead space (i.e. sphenoid sinus); 
therefore, optimizing the flap position and increasing 
its anterior reach. Finally, the reconstruction is bolstered 
with nasal packing.
In patients where the Hadad-Bassagaisteguy 
flap is not available (due to tumor invading the nasal 
septum, sphenoid rostrum or pterygopalatine fossa, or 
previous surgical resection of the septum), a pericranial 
flap should be considered18,19. The scalp hair is parted 
following the planned coronal incision but no hair is 
shaved. After sterile preparation and injection with 
lidocaine 1% with epinephrine 1/100,000 a coronal 
incision is carried down to the calvarium (between the 
temporalis muscles) or down to the superficial layer of 
the deep temporal fascia (over the temporalis muscles). 
Alternatively, a subgaleal dissection, posterior to the 
coronal incision may be used to increase the length of 
the pericranial flap. The scalp is elevated from the skull 
in a caudal direction to reach the orbital rims, and to 
identify the supraorbital and supratrochlear neurovascu-
lar bundles. Once the neurovascular bundles have been 
dissected from their corresponding notches or foramina, 
the scalp dissection continues caudally to expose the 
nasion and nasal bones. The loose areolar tissue and 
periosteum (i.e. pericranium) are subsequently elevated 
from the galea (unilateral) following a cephalo-caudal 
direction and narrowing down to about 3 cm at the 
level of the pedicle (unilateral).
A high-speed drill with a 4 mm cutting or coarse 
diamond burr is used to open a window at the level of the 
765
Brazilian Journal of otorhinolaryngology 79 (6) novemBer/DecemBer 2013
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
nasion into the nasofrontal recesses. The pericranial flap 
is then transposed through the window under endoscopic 
visualization, preventing torsion of the vascular pedicle. 
The pericranial flap is gently pressed down and flattened 
to cover the inlay fascial graft, exposed dural edges, and 
the surrounding bony framework of the defect with an 
extradural extracranial onlay technique.
Endoscopic endonasal transpterygoid 
extension
Tumors involving the nasopharynx, pterygopalatine 
(PPF) or infratemporal fossa (ITF), require resection via a 
transpterygoid corridor. The initial steps of the approach 
are usually performed through the predominantly involved 
nostril. An ipsilateral ethmoidectomy, wide sphenoidotomy 
and medial maxillectomy (with or without an anterior 
extension or an endoscopic Denker’s approach) create 
a large “single chamber” corridor that allows unimpeded 
lateral visualization and instrumentation.
Specifically, a transpterygoid approach requires 
a minimum of a wide midmeatal naso-antral window 
(NAW) that should be maximized extending the opening 
antero-posteriorly, from the nasolacrimal duct to the 
posterior antral wall and cephalo-caudally from the floor 
of the orbit to the superior aspect of the inferior turbi-
nate. This midmeatal naso-antral window adequately 
addresses lesions above the vidian canal. Malignancies, 
however, often extends below the vidian canal; thus, 
an appropriate transpterygoid approach will demand 
an endoscopic medial maxillectomy extending from the 
inferior orbital wall to the floor of the nasal cavity and 
from the nasolacrimal duct to the posterior wall of the 
antrum. This exposes the entire height of the posterior 
wall even using a 0° rod lens endoscope. Occasionally, 
the medial maxillectomy needs to be extended anterior-
ly to provide enhanced lateral exposure for extensive 
tumors in the infratemporal fossa. This may even require 
an endoscopic Denker’s approach, which includes the 
removal of the remaining inferior turbinate, anterior 
aspect of the inferior meatus and anterior wall of the 
maxilla (Figure 2). Exposure of the piriform aperture 
requires a vertical incision just anterior to the head of 
the inferior turbinate, over the edge of the aperture. 
This edge can be palpated with a blunt dissector to 
optimize the placement of the incision, which is then 
carried through the periosteum to facilitate a subpe-
riosteal exposure of the anterior maxilla. The medial 
maxillectomy is then extended anteriorly to remove the 
piriform aperture and sufficient anterior maxillary wall 
to expose the entire lateral wall of the antrum.
An anterior extension of the medial maxillectomy 
may be tailored to the specific visualization need, e.g. 
Figure 2. A-B: Intraoperative photographs demonstrating the resection 
of a right ethmoidal adenocarcinoma. Firstly, the tumor is debulked to 
identify it origin; C-D: Subperiosteal dissection of the tumor separates 
it from the medial orbital wall, nasoethmoidal complex and nasofrontal 
recess; E: The dissection continues along the maxillary line and pos-
teriorly, along the lamina papyracea, to reach sphenoid sinus; F: The 
left middle turbinate is removed to establish an adequate margin and 
to expand the space for instrumentation; G-H: Wide sphenoidotomies 
establish the posterior margin; I: Residual tumor at the anterior aspect 
of the medial wall of the maxillary sinus cannot be adequately removed 
via a midmeatal antrostomy; J: An endoscopic medial maxillectomy is 
performed with the resection of the inferior turbinate; K: The resection 
extends from the orbit down to the floor of nose; however, its’ exposure 
is insufficient. Therefore, an endoscopic Denker’s approach is deemed 
necessary for a full exposure; L: The piriform aperture and ascending 
process of the maxilla are removed, dissecting the nasolacrimal duct 
and transecting it sharply. Exposure of the piriform aperture requires 
a vertical incision on the edge of the aperture; M-N: This edge can 
be palpated with a blunt dissector to optimize the placement of the 
incision, which is then carried through the periosteum down to bone. 
A subperiosteal lateral dissection exposes the anterior maxilla. The 
medial maxillectomy is then extended to remove the piriform aperture 
and sufficient anterior maxillary wall to expose the entire confines of the 
antrum; O-P: This corridor facilitates the adequate resection of tumor 
with negative margins; T: Tumor; MT: Middle turbinate; FS: Frontal 
sinus; SS: Sphenoid sinus; MS: Maxillary sinus; IT: Inferior turbinate.
confining it to removal of the lateral wall inferior to the 
nasolacrimal opening. However, a full Denker’s appro-
ach includes removing the anteromedial aspect of the 
ascending process of the maxilla (piriform aperture), 
dissecting and transecting the lacrimal duct sharply. This 
allows a line of sight that extends to the most lateral 
aspect of the infratemporal fossa.
Following a wide midmeatal naso-antral window 
or a medial maxillectomy, the mucoperiosteum covering 
the superior third of the posterior wall of the antrum and 
the corresponding level over the perpendicular plate 
of the palatine bone is elevated to identify the spheno-
palatine foramen. Using 1-2 mm Kerrison’s rongeurs, 
the anterior aspect of the sphenopalatine foramen can 
be removed to expose the pterygopalatine fossa. Bone 
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removal is extended inferiorly to reach the level of the 
antral floor, and laterally to reach the inferior orbital 
fissure. Cautious dissection of the medial aspect of the 
posterior wall of the maxillary sinus is necessary, as it 
forms part of the descending palatine canal containing 
the greater palatine nerve and descending palatine 
artery. After the exposure is attained, the tumor can be 
removed from the pterygopalatine fossa, identifying and 
controlling the internal maxillary artery.
Extension of the tumor into the middle cranial 
base or infratemporal fossa mandates the resection 
of pterygoid process to provide adequate access to 
the tumor. Initially, the ipsilateral sphenoidotomy is 
extended laterally, opening the lateral recess of the 
sphenoid sinus. When tumor extends to the middle 
cranial base (i.e. petrous apex or Meckel’s cave), 
it is essential to drill the sphenoid sinus floor until 
it becomes flush with the level of the clival recess. 
Subsequently, the vidian canal is dissected until the 
transition from paraclival (vertical) to petrous ICA 
(horizontal) is identified visually and confirmed with 
an acoustic Doppler sonography. One should proce-
ed with removing the tumor from petrous apex and 
Meckel’s cave only after the exposure (i.e. removal of 
the pterygoid base) is deemed adequate.
To enter the infratemporal fossa, the trunk of the 
internal maxillary artery is divided at the pterygoma-
xillary fissure, whereas the vidian neurovascular bundle, 
and the branch of the sphenopalatine ganglion to CN 
V
2
 are divided just distal to their respective foramina. 
This exposes the entire height of the anterior aspect of 
the pterygoid process. A subperiosteal elevation avoids 
bleeding from the pterygoid plexus while dissecting 
the lateral and medial pterygoid muscles; which are 
detached before drilling out the lateral pterygoid plate. 
After complete removal of the pterygoid process, the 
infratemporal fossa can be accessed to extirpate the 
tumor. Several surgical landmarks should be taken 
into consideration throughout the approach: foramen 
ovale and CN V
3
 (identified just posterior to the base 
of the lateral pterygoid plate); the tensor veli palatini 
muscle (between the pterygoid plates and just anterior 
to the Eustachian tube); the cartilaginous Eustachian 
tube (anterior to the petrous and parapharyngeal ICA 
and posterior to V
3
).
Aggressive tumors that invade the pterygoid mus-
cles are best managed by an open approach that allows 
the exenteration of the infratemporal fossa. Intraoperati-
ve histological analysis of the surgical margins after any 
resection is ideal regardless of the surgical approach.
Reconstructive technique
After a complete resection is confirmed (negative 
margins) by intraoperative histological analysis, the 
reconstruction recreates the arachnoid layer using an 
inlay graft of collagen matrix (e.g. DuraGen; Integra 
LifeSciences Corp., Plainsboro, NJ). The nasoseptal flap 
is then onlaid overlapping the defect widely (allowing 
for some tissue contraction). Gelatin foam (Gelfoam; 
Upjohn Co., Kalamazoo, MI) Nasopore (Stryker Corp; 
Kalamazoo, MI) creates a non-adherent barrier between 
the flap and the nasal packing. Occasionally, a free fat 
graft is inserted prior to obliterate a significant dead 
space such as the sphenoid sinus or clival recess; the-
refore, enabling an optimal flap positioning and longer 
reach. If the Hadad-Bassagaisteguy flap is not available, 
an alternative reconstructive technique should be con-
sidered, either a vascularized flap (i.e. temporoparietal 
fascia flap17,occipital galeopericranial flap30,31, middle 
turbinate16 or inferior turbinate flaps14,15, and lateral 
nasal wall flap22,23) or free tissue graft. Most commonly, 
we use a temporoparietal fascia flap inserted through 
a transpterygoid tunnel.
A temporoparietal fascia flap is harvested via a 
hemicoronal incision and its passage into the nasal cavity 
is facilitated by a tunnel that connects the temporal fossa 
to the infratemporal fossa and eventually to the nasal cavity 
via the pterygopalatine fossa. This tunnel requires varying 
degrees of expansion using dissection, bougienage and 
partial removal of the pterygoid process. The geometry 
and dimensions of the pterygopalatine fossa, antrum and 
the soft tissue flap, dictate the dimensions of the tunnel. Fi-
nally, the reconstruction is bolstered in place using sponge 
packing, the balloon of a Foley catheter or both. Silicone 
splints are used to protect the nasal septum, if needed.
Endoscopic nasopharyngectomy
Indications and limitations
Surgery for primary nasopharyngeal carcinoma 
has a limited role, as radiotherapy is the mainstay of 
treatment. Most often, surgery serves to provide tissue 
samples or to alleviate compressive symptoms. Ho-
wever, current evidence supports that surgery play a 
significant role in carcinomas of glandular origin and 
for persistent or recurrent loco-regional disease32-35. 
Surgical resection is one of many acceptable options 
among a variety of modern re-irradiation techniques 
including stereotactic, brachytherapy, proton, or inten-
sity modulated therapy36-42. Furthermore, surgery plays a 
primary the role in the treatment of radioresistant tumors 
such as adenocarcinoma, adenoid cystic carcinoma, 
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mucoepidermoid carcinoma, and sarcomas. Primary 
resection of these tumors seems advantageous43.
Endoscopic endonasal nasopharyngectomy 
is a challenging operation. Transpterygoid approa-
ches provide exposure to all lateral sub-sites of the 
nasopharynx, including the infratemporal fossa. Howe-
ver, encasement of the parapharyngeal ICA or extension 
of the tumor posterior to the ICA (parapharyngeal or 
petrous segments) is considered a contraindication to 
an endoscopic resection with curative intent. These 
extensions require an open approach such as the pre-
auricular or post-auricular subtemporal approaches44.
Surgical technique (Figure 3)
Intuitively, the extent of the endoscopic endona-
sal approach and resection matches the tumor location 
and extensions. A small localized lesion on the central 
nasopharynx may be resected via a transnasal corridor 
(including removal of the posterior part of inferior tur-
binate and a limited infero-posterior septectomy) that 
allows adequate visualization and facilitates bi-lateral 
instrumentation. This conduit offers the possibility to 
resect the posterior and superior nasopharyngeal walls 
including the bony floor of the sphenoid sinus. Fur-
thermore, the resection can extend antero-superiorly 
to include the anterior wall and the sphenoid sinus. 
It may also be extended inferiorly to the level of C
2
 
Unfortunately, the tori tubarius are often involved; 
thus, the resection of the medial cartilaginous portion 
of the affected Eustachian tube is required. The 
posterolateral wall of the nasal cavity is incised just 
posterior to the inferior turbinate (ascending process 
of the palatine bone) and a mucoperiosteal dissection 
follows to expose the medial aspect of the medial 
pterygoid. This subperiosteal plane may be followed 
to elevate the soft tissues covering the roof of the 
nasopharynx and facilitating the transection of the torus.
Lateral involvement of the fossa of Rosenmüller 
requires a transpterygoid approach including a medial 
maxillectomy and transposition of the soft tissue 
contents of the medial pterygopalatine fossa to expose 
the entire height of the pterygoid process, and to allow 
the removal of the medial pterygoid plate and its base 
(to the level of foramen rotundum). Any anatomical 
variation requiring a modification of this template can 
be identified and planned for using the preoperative 
imaging.
Whenever possible the lateral pterygoid plate is 
preserved as it serves as a landmark to mark the position 
of V
3
 (just posterior to its base) and the parapharyngeal 
ICA (posterior to V
3
); therefore, these three structures 
align on the sagittal plane. Tumor extension to the 
pterygopalatine fossa and infratemporal fossa requires 
expansion of the transpterygoid corridor (discussed 
above). The dimensions of this corridor depend on 
the geometry and pneumatization of the maxillary 
sinus and nasal cavities (inherent), and the extension 
of the tumor (to be followed by the surgeon). If 
the endoscopic medial maxillectomy only affords a 
limited exposure of the infratemporal fossa, we can 
extend it anteriorly (endoscopic Denker’s approach) 
as previously discussed.
After complete exposure of the posterior wall of 
maxillary sinus, the pterygopalatine soft tissue contents 
are meticulously dissected and the bone around the 
vidian canal and foramen rotundum is drilled out in an 
anterior to posterior fashion. The mandibular branch 
of the trigeminal nerve (CN V
3
) is identified anterior to 
the petrous ICA and under CN V
2
. Following the iden-
tification of the lacerum segment of the ICA’s, the bone 
covering its petrous (horizontal) segment is removed 
laterally. When distal control of the ICA is necessary, the 
bony canal over the paraclival carotid (vertical segment) 
is also removed. Dissection of the tumor along the ICA 
is performed with great care, confirming the position 
and trajectory of the vessel with both the intraoperati-
ve navigation and acoustic Doppler sonography. The 
medial Eustachian tube is transected and removed to 
Figure 3. A-D: Intraoperative photograph demonstrating tumor at 
superior wall of nasopharynx. An incision is made just above the torus 
tubarius A allowing a subperiosteal dissection of the basisphenoid 
and clivus; E-K: A posterior septectomy and sphenoidotomies are 
performed; and the sphenoid sinus intersinus septa are removed; L: 
Finally, histological analysis is required to confirm the negative surgical 
margins. Rt. SS: Right sphenoid sinus; Lt. SS: Left sphenoid sinus; 
NS: Nasal septum; IT: Inferior turbinate.
(second cervical vertebra), and posteriorly to reach the 
periosteum of the clivus.
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expose the entire fossa of Rosenmüller and the tumor 
within. The tumor is removed en bloc or in sequential 
layers according to its relationship to critical neurovas-
cular structures.
Reconstructive Technique
Reconstruction of the surgical defect, including 
coverage of the middle cranial and/or posterior cranial 
fossae and exposed ICAs, must be carefully planned 
including the possibility of needing alternative options. 
Harvesting of a contralateral Hadad-Bassagaisteguy flap 
must be completed at the beginning of the surgery 
and stored in its ipsilateral maxillary antrum, sphenoid 
sinus or against the lateral nasal wall. The Caicedo 
reverse flap is raised and mobilized to cover the sep-
tal cartilage donor site, left bare after harvesting the 
Hadad-Bassagaisteguy flap.
Following histological confirmation of tumor-free 
surgical margins, the defect is reconstructed in similar 
fashion to that previously described using a collagen 
matrix graft and a vascularized flap. However, if the 
extent of the defect is larger than the potential cove-
rage of the Hadad-Bassagaisteguy flap, or this flap is 
not available, reconstruction proceeds with a tempo-
roparietal fascia flap. The latter can be introduced into 
the nose via a transpterygoid tunnel to cover exposed 
dura and/or ICA17,45.
Endoscopic transclival resection
Indications and limitations
Malignant tumors invading or originating from 
the clivus are rare, but usually aggressive and locally 
destructive tumors (i.e. chordomas, chondrosarcomas). 
Radical resection and postoperative radiotherapy are 
the standard treatment modalities. However, surgical 
approaches to the clivus are challenging due to its intri-
cate and deep-seated anatomy with abundant adjacent 
critical neurovascular structures.
Endoscopic endonasal transclival approaches 
provide the most direct route to the median, ventral 
posterior fossa without retraction of brain. Rostrally, 
they can access the retrosellar region, extending to the 
interpeduncular fossa (via a pituitary transposition)46; 
whereas caudally, the can effectively extend to the level 
of C
2
5. Lateral exposure can be extended incorporating 
a transpterygoid corridor. If an endonasal access does 
not provide adequate lateral access, the tumor resection 
may be staged, using an external lateral approach to 
address any residual tumor.
In general, the guiding principle for the resection 
is to avoid crossing nerves; thus, an EEA is best to ac-
cess tumors ventral to the cranial nerves. A significant 
dorsal extension requires an alternative approach (as 
an adjunct). Other limitations include significant lateral 
extension to the cavernous sinus or the paraclival carotid 
artery or marked posterolateral extension encasing the 
basilar and/or vertebral arteries or invading brain stem47.
Surgical technique (Figure 4)
The sinonasal corridor is created as previously 
described to combine the posterior nasal cavities into 
single conduit. This allows for exposure of the sella, 
the upper third of the clivus, and the paraclival ICA. 
Lateral widening of the sphenoidotomy expose the 
lateral recesses (bilateral). Exposure of the middle and 
lower thirds of the clivus is completed with the removal 
of the mucosa of the nasopharynx and the underlying 
basopharyngeal fascia and the insertion of the longus 
capitis muscles. Subperiosteal dissection should keep 
Figure 4. A: Malignant clival tumor extending laterally beyond the para-
clival ICA; therefore, requiring endoscopic transpterygoid. After a total 
ethmoidectomy and bilateral sphenoidotomies, a medial maxillectomy 
is completed to access the pterygoid process; B: The sphenopalatine 
artery is coagulated before removing the posterior wall of maxillary 
sinus; C: The greater palatine canal opened and the descending 
palatine artery and the greater palatine nerve are freed. Sequentially, 
the vidian nerve is transected to allow the lateral displacement of the 
soft tissue contents of the pterygopalatine fossa; D: After adequate 
exposure of anterior aspect of the pterygoid process; E-F: The floor 
of the sphenoid sinus is drilled flush with the level of the clival recess; 
G-H: Subsequently, the vidian canal is dissected and the ICA position is 
confirmed with nasal acoustic Doppler sonography; I-J: Removal bony 
of the pterygoid base enhances the exposure for tumor removal from 
the clivus; K-M: The medial pterygoid plate and Eustachian tube are 
removed; N-O: Allowing a total resection of the clival tumor with ade-
quate margins; P: Finally, the HBF is placed to cover the defect and ICA. 
MS: Maxillary sinus; SS: Sphenoid sinus; HBF: Hadad-Bassagaisteguy 
nasoseptal flap; V: Vidian nerve; ICA: Internal carotid artery; M. Pt: 
Medial pterygoid artery; T: Tumor; ET: Eustachian tube.
between the Eustachian tubes, particularly when using 
the electrocautery, as the ICAs run just lateral and 
posterior to the Eustachian tubes46,48,49. Occasionally, 
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the ICAs may be ectatic (more common in the elderly) 
and at a median position between the Eustachian tubes. 
This should be identified in the preoperative imaging.
Removal of the clivus is performed using a 
high-speed drill with a 3-4 mm hybrid or coarse dia-
mond burr. The venous plexus posterior to the clivus 
(basilar plexus) is quite rich and bleeds significantly; 
thus, requiring frequent plugging with hemostatic paste, 
microfibrillar cellulose, or gelatin sponge.
Tumor extending lateral or posterior to the pla-
ne of the paraclival or petrous ICA mandate surgical 
control of these segments. The anterior genu between 
the horizontal petrous segment and the vertical para-
clival ICA (at the level of the foramen lacerum) is best 
identified by the vidian artery and nerve running in the 
vidian canal50,51.
A transpterygoid approach is performed follo-
wing the previously described technique to expose the 
Eustachian tube. The ICA anterior genu is by drilling 
out the exposed “medial pterygoid wedge”. Once the 
ICA is isolated, it can be mobilized lateral and cepha-
lad, providing access to tumor extending posterior to 
it. An endoscopic Denker’s approach can be added 
for extended lateral access, facilitating removal of the 
medial and lateral pterygoid plates and adjacent soft 
tissue. This is most commonly required to gain con-
trol of the parapharyngeal ICA, using the Eustachian 
tube and V
3
 as superficial landmarks. In addition to its 
lateral access, this approach provides a corridor that 
facilitate the removal of tumor extending to the foramen 
magnum, hypoglossal canal, medial occipital condyle, 
and jugular foramen. Therefore, using a combination 
of approaches one can achieve complete control and 
mobilization of the ICA (parapharyngeal, horizontal 
petrous, anterior genu, and vertical paraclival segments), 
and allow access to tumor to the ICA from both medial 
and inferior trajectories.
Inn addition to the ICA, one must remain cog-
nizant of the course of any involved cranial nerves, 
especially the CN VI, which can be injured at every 
stage of the approach and resection. Bone drilling or 
tumor resection adjacent or posterior to the superior 
paraclival ICA, can damage CN VI as it exits Dorello’s 
canal and courses toward the cavernous sinus. Another 
critical anatomic landmark to avoid injury to CN VI is to 
realize its relationship to the vertebrobasilar junction52. 
CN VI arises at the level of the vertebrobasilar junction 
and then runs obliquely in the prepontine cistern to 
Dorello’s canal. The best way to avoid injury at this area 
is to open the dura (when needed) below the antici-
pated location of the vertebrobasilar junction at appro-
ximately the level of the basion (roughly corresponds 
to the floor of the sphenoid sinus). We prefer to use a 
bimanual “2-suction” technique for internal debulking 
of soft or gelatinous tumors such as chordomas or 
chondrosarcomas53. Intradural resection is limited by 
adherence of the tumor capsule to perforator vessels, 
cranial nerves, and brainstem. Therefore, the presence 
of subarachnoid planes becomes a limit of the surgery 
regardless of the surgical approach. To that end, tumor 
should never be blindly pulled. If needed, the exposure 
should be extended and dissection should be performed 
only under direct visualization53.
Reconstruction technique
Reconstruction of the resulting defect most com-
monly uses an intradural collagen matrix graft (or fascia 
lata) and the Hadad-Bassagaisteguy flap as previously 
described. A temporoparietal fascia flap is recommen-
ded if the nasoseptal flap is not available. A long bony 
tunnel, created during the transclival drilling, may 
require obliteration with free abdominal fat to allow a 
full coverage with the flap. A temporary packing (3-5 
days) bolsters the reconstruction. Gelatin foam (e.g. 
Gelfoam; Upjohn Co., Kalamazoo, MI) or Nasopore 
(Stryker Corp; Kalamazoo, MI) applied over the flap 
creates a non-adherent barrier between the flap and 
the nasal packing.
POSTOPERATIVE CARE
Upon completion of the surgery, the patient is 
transferred to a monitored unit that facilitates early detec-
tion of complications and provide attention to fluid and 
metabolic disturbances that can occur during the early 
postoperative period; i.e. two common postoperative 
disturbances include diabetes insipidus (DI) and the syn-
drome of inappropriate secretion of antidiuretic hormone 
(SIADH). In addition, the physician should be alert to 
others major complications that can occur after skull base 
surgery, especially significant intracranial hemorrhage 
or tension pneumocephalus. These early complications 
may be identified with a postoperative non-contrasted 
CT scan immediately after surgery (on a stable patient). 
We also advocate a contrasted MRI within the first 24 
hours after surgery to corroborate the completion of the 
resection. In addition, the contrast uptake may provide 
an idea of the vascularity of the reconstructive flap as 
well as the adequacy of its positioning.
Indwelling lumbar spinal drainage is rarely indica-
ted. We reserve its use for patients who are considered 
at high risk for increased intra-ventricular pressure and 
for those with an intraoperative high-flow leak (defined 
as opening of the third ventricle or at least 2 cisterns).
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DISCUSSION
Advances in endoscopic endonasal surgery 
have enabled the extirpation of sinonasal carcinoma. 
Endoscopic resection techniques include a step-by-step 
dissection based on anatomical principles, constant as-
sessment of tumor boundaries followed by, a piecemeal 
or layered removal and intraoperative histological 
analysis of surgical margins. Recent publications sup-
port the oncologic adequacy the endoscopic endonasal 
approaches even when the tumor is not removed en 
bloc. Conversely, one should not assume that the use 
of an open approach assures better margins. Patel et 
al.54, reported a multinational, multi-institutional study 
of anterior craniofacial resections in which close to a 
third of the patients (32%) had close or positive margins. 
This can be explained by the the complex relationship 
of these tumors to the critical anatomy of the skull base, 
which in turn drives the surgeon to remove the tumor 
with minimal margins in order to preserve a vital struc-
ture (in these cases quality of life and safety supersedes 
the standard oncological wide margins).
One difficulty when analyzing the data regarding 
endoscopic surgery is the different terminology regarding 
what constitutes an endoscopic endonasal or endoscopic-
-assisted surgery. We will only discuss those studies in 
which the use of the endoscope was clearly defined as 
the only visualization tool during an endonasal approach 
and resection (i.e. pure endoscopic endonasal approach 
reconstructed with free tissue grafts, or endonasal or 
regional flaps) and those in which a craniotomy with 
or without a sub-basal approach was combined with an 
endonasal endoscopic approach to avoid facial incisions 
(i.e. endoscopic-assisted or cranioendoscopic approach). 
Those case series in which the endoscope was used to 
inspect the surgical field through standard open approa-
ches will not be discussed.
Higgins et al.55 conducted a systematic review 
comparing the oncologic outcomes after endoscopic 
endonasal approaches and those of traditional open 
approaches. Both techniques yielded similar outcomes 
(difference not statistically significant), including 
5-year overall survival (87.4 ± 5.3% in the endoscopic 
group and 76.8 ± 8.3% for open approach; p = 0.351), 
disease-specific survival (94.7 ± 3.7% in the endoscopic 
group and 87.7 ± 6.7% for open approach; p = 0.258), 
and locoregional control rate (89.5 ± 5.0% in the en-
doscopic group and 77.2 ± 10.4% for open approach; 
p = 0.251).
Others, however, have reported differences in 
outcomes. Eloy et al.56 published their experience after 
open and endoscopic endonasal anterior skull base 
resection of sinonasal malignancies reporting no signifi-
cant statistical difference in overall survival (endoscopic 
group = 94.4% vs. open craniofacial group = 83.3%). 
Nonetheless, the difference in local recurrence rate did 
approach statistical significance (5.6% for the endos-
copic group and 29.2% for open craniofacial group; 
p < 0.05)). Kim et al.57 studied 40 sinonasal malignancies 
(19 esthesioneuroblastoma, 7 squamous cell carcino-
ma, 3 malignant melanoma, and 11 others) invading 
the anterior skull base. Their outcomes regarding 
local recurrence were similar to those of Eloy et al.56, 
demonstrating that 11% of the patients undergoing an 
endoscopic approach developed a recurrence; whereas 
55% of those undergoing an open approach recurred. 
One should recognize a strong patient selection bias 
in both studies, as a larger proportion of tumors with 
advanced stages was treated by the open approach. In 
addition, Kim et al.57 inappropriately mixed benign and 
malignant lesions in their analysis.
Suh et al.58 assessed the outcomes of endosco-
pic and endoscopic-assisted resection (i.e. craniotomy 
or sub-basal approach combined with endoscopic 
endonasal approach) in a case series including hete-
rogeneous histologies including sarcomas (9 patients), 
squamous cell carcinomas (8 patients), adenocar-
cinomas (8 patients), and melanomas (7 patients). 
The 3-year disease-free survival rate was 86.8% for 
the endoscopic endonasal group and 67.7% for the 
endoscopic-assisted open group with a mean follow up 
time of 3.58 years. Overall local tumor recurrence rate 
was 16% and disease-specific mortality was 8%. These 
outcomes are similar to those of a large retrospective 
series published by Nicolai et al.59, who reported a 
5-year disease-specific survival of 91.4 ± 3.9% for an 
endoscopic-endonasal cohort, which was superior to the 
5-year disease-specific survival for a cranioendoscopic 
(i.e. endoscopic-assisted) group, which was 58.8 ± 8.6%. 
Recurrent disease was observed in 23.6% for the entire 
patient cohort (43/182), and included 19% (25/133 pa-
tients) of the endoscopic group and 37% (18/49 patients) 
of the cranioendoscopic group; therefore, suggesting 
that endonasal endoscopic and endoscopic-assisted 
approaches for the management of adequately selected 
sinonasal malignancies are a reasonable alternative to 
traditional open approaches. However, some remaining 
controversies require further study with stratification of 
survival data by histology and stage, as well as longer 
follow up60.
Similarly, in a meta-analysis by Devaiah & 
Andreoli61 endoscopic approaches provided superior 
survival rates (p = 0.0019), even when stratifying for 
publication year (p = 0.0018). Median follow-up was 51 
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months for patients undergoing a traditional craniofacial 
resection and 54.5 months for those in the endoscopic 
group. These apparently “superior” outcomes after 
endoscopic endonasal resection should be carefully 
interpreted, considering confounding factors such as 
follow-up times, stage, invasiveness, and histopathology 
that undoubtedly influenced these results.
Nonetheless, a study of esthesioneuroblastoma by 
Folbe et al.62 suggests that Kadish C and D tumors can 
be effectively treated using an endoscopic endonasal 
approach followed by postoperative radiation therapy. 
This series included patients with esthesioneuroblasto-
mas that were staged as Kadish A (10.5%), B (58.9%), C 
(26.3%), and D (5.3%); with an average follow-up (pri-
marily treated cases) of 45.2 months (11-152 months). 
At the time of publication all patients were alive and 
free of disease. Similar findings have been recently 
reported study by Gallia et al.63, who presented their 
experience resecting esthesioneuroblastomas via endos-
copic endonasal approaches (modified Kadish stage A 
(18.2%); stage B (18.2%); stage C (45.5%); and stage D 
(18.2%). All patients underwent a complete resection 
obtaining negative margins intraoperatively; and, at an 
average follow-up of over 28 months, all patients were 
alive and free of disease. Of note, the mean period to 
develop a recurrence is 6 years64; therefore, long-term 
follow-up seems critical.
In addition, it is important to recognize that the 
management of sinonasal tumors with anterior skull 
base involvement remains multimodal. Despite some 
remaining controversy, most patients with sinonasal ma-
lignancies are treated with a combination of surgery and 
radiation therapy. Outcomes after treatment including 
neoadjuvant chemotherapy followed by surgery and 
postoperative radiation therapy or primary radiation the-
rapy were evaluated by Song et al.65, who retrospectively 
studied 35 patients including 7 who were treated with 
chemoradiotherapy, 12 who underwent a traditional cra-
niofacial resection, 11 an endoscopic-assisted resection, 
and 5 patients who had a pure transnasal endoscopic 
resection. At an mean follow-up period of 64.9 months 
the 5-year disease free survival rate was 35.7% for the 
nonsurgical treatment group, 41.7% for the traditional 
craniofacial resection, 80.8% for the endoscopic-assisted 
resection, and 100% for the purely transnasal endosco-
pic resection (p = 0.01) groups. Overall local recurrence 
was observed in 23% of the patients, but specifically in 
33% of patients after traditional craniofacial resection, 
9% after endoscopic-assisted resection, and 14% after 
nonsurgical treatment. No recurrences were observed 
in patients who underwent a purely endoscopic trans-
nasal resection.
Endoscopic endonasal surgery is an important 
modality of treatment for tumors involving the posterior 
cranial base including nasopharynx, clivus and 
craniovertebral junction (i.e. nasopharyngectomy, transclival 
resection). Endoscopic endonasal nasopharyngectomy 
plays an important role in residual or recurrent 
loco-regional tumor, and malignancies of glandular 
and mesenchymal origin. In addition, surgical 
resection followed by adjunctive radiation therapy 
remains the mainstay treatment for chordomas and 
chondrosarcomas.
Similar to the resection of the anterior skull base, 
a nasopharyngectomy can be performed using various 
open approaches (i.e. maxillary swing, LeFort I, preau-
ricular temporal-subtemporal) or endoscopic endonasal 
approaches. Their oncologic outcomes seem similar 
assuming an adequate selection of patients. Chan et al.66 
reported the largest retrospective review of outcomes 
in 268 patients after salvage nasopharyngectomy via 
maxillary swing. These authors reported that they were 
able to obtain clear resection margins in 79.1% of pa-
tients, obtaining a 5-year actuarial local tumor control 
and overall survival was 74% and 62.1%, respectively 
(median follow up of 52 months). Conversely, early re-
ports analyzing the outcomes of endoscopic endonasal 
nasopharyngectomy demonstrated a 2 year disease free 
survival rates of 57.6-86.3%, and 2 year overall survival 
rates of 59.4-100%67-69. These series suggested that the 
endoscopic endonasal approach was beneficial for 
patients with early stage carcinomas. Nonetheless, in a 
series of extended endoscopic transpterygoid nasopha-
ryngectomy for advanced primary and recurrent malig-
nancies published by Al-Sheibani et al.43 early outcomes 
demonstrated an overall survival of 45% (9/20) and a 
local control of 65% (13/20). These outcomes have 
been reproduced by Castelnuovo et al.70, who recently 
reported their experience with endoscopic nasopha-
ryngeal resection, including patients with advanced 
stage. Their study included 36 consecutive patients with 
primary (9 patients) and locally recurrent (27 patients) 
nasopharyngeal carcinomas, including patients with 
stage I (44.4%), stage II (8.4%), stage III (41.6%), and 
stage IVA (5.6%) and a mean follow up period of 38 
months. Overall oncologic outcomes at 5 years survival 
rate, disease specific, and disease free survival were 
75.1 ± 9.13%, 80.9 ± 7.79%, and 58.1 ± 14.8%, respec-
tively. However, the reproducibility and efficacy of 
endoscopic transpterygoid nasopharyngectomy require 
validation with larger case series and longer follow up.
Recently, the use of the Da Vinci robot (Intuitive 
Surgical, Sunnyvale, California) has been sugges-
ted as an adjunctive tool to facilitate of skull base 
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surgery. It provides three-dimensional (3D) visuali-
zation, affords 2 to 3-handed surgery (robotic arms 
and co-surgeon/assistant’s), and has the advantage 
of wristed instruments that improve the ability to ma-
nipulate the tissue (e.g. dural resection or repair)71,72. 
The potential for robotic skull base surgery has been 
evaluated in various cadaveric models73-78. Hanna et al.79 
described a bilateral transantral approach to facilitate 
accessing the anterior and central skull base. Dallan 
et al.80 reported a feasibility study illustrating the ad-
vantages of a transnasal-transcervical/transoral robotic 
surgery. These authors studied the feasibility of using 
the robotic camera through the nasal cavity and inserting 
transcervical/transoral trocars as corridors for the Endo-
wrist robotic arms, as previously suggested by O’Malley 
& Weinstein74, as well as Lee et al.78. They concluded 
that this combined technique avoided the need for a 
palatal transection and that it seemed adequate for the 
resection of small tumors. Various approaches using 
combinations of camera corridors and Endowrist ins-
trument ports were assessed by Ozer et al.71 A transoral 
camera (30°) and instruments provided good control 
of the posterior and lateral nasopharynx; but access to 
the roof of the nasopharynx was inadequate. A trans-
nasal camera (0°) and transoral instruments provided 
great visualization but instrumentation was limited and 
cumbersome. Overall, the transpalatal approach (hard 
palate) offered the best combination of visualization 
and ease of instrumentation. Adjunctive transcervical 
ports for the Endowrist instruments, however, provided 
superior range and ease of instrumentation with all the 
camera corridors.
It should be noted, however, that the robot does not 
have a drill or suction device. Therefore, the endoscopic 
endonasal techniques complement the robotic techniques, 
allowing drilling of the skull base and controlling areas 
not fully accessed by the robotic approach. Yin et al.81 
were the first to report the clinical use of an endoscopic 
endonasal approach combined with a transoral robotic 
resection of a small recurrence at the superior aspect of the 
nasopharynx, Subsequently, a combined technique, using 
transoral robotic surgery and an endoscopic transpterygoid 
approach, to remove extensive malignant tumors of the 
posterior skull base, nasopharynx and ITF was developed 
and applied by Carrau et al.82
Tumors in the clival region present challenges 
to the surgical team due to their encroaching nature, 
proximity to critical neurovascular bundles and large 
volume at presentation. Chordomas and chondrosar-
comas are the most common clival malignant tumors 
and their therapy options include surgery and various 
forms of radiotherapy. Regarding the philosophy and 
technical approaches for the surgical resection of the 
clival region they range from the conventional open 
to minimally invasive endoscopic endonasal approa-
ches. Their oncologic outcomes have been demons-
trated. Gay et al.83 described their experience with a 
variety of open approaches including subtemporal, 
transzygomatic, transcavernous, and transpetrous apex; 
subtemporal and infratemporal; extended frontal; and 
extreme lateral transcondylar approaches in 60 patients. 
These approaches allowed a total or near total resec-
tion of 67% and a recurrence-free survival rate of 80% 
at 3 years and 76% at 5 years. Another large series by 
Di Maio et al.84, described their experience with open 
surgical resection of chordomas in 90 patients, yielding 
a 5-year overall and recurrence free survival of 74 ± 6% 
and 56 ± 8%, respectively. These results were similar to 
studies reporting clinical series of cranial base chordoma 
resected by open approaches that reported a complete 
resection rate that ranged from 23.1% to 71.6%. 5-years 
progression free survival ranged from 15% to 64%, and 
5-years overall survival ranged from 65% to 82.4%85-89.
Similarly, outcomes of endoscopic transclival 
resection have been reported by several studies. Fraser 
et al.90 reported that > 95% resection was achieved in 
7 of 8 operations (5 of 6 patients), and 80% of the tu-
mors was resected in the remaining patient. Holzmann 
et al.91 found that endoscopic endonasal approaches 
yield radical or near total removal of clival chordoma in 
12/13 patients. Stippler et al.53 presented the treatment 
of the 12 newly diagnosed chordomas including 8 total 
resections (66.7%), 2 near total resections (16.7%), and 
2 subtotal resections (16.7%). Endoscopic surgery of 8 
recurrent chordomas included 1 gross total resection 
(12.5%), 2 near total resections (25.0%), and 5 subtotal 
resections (62.5%). Two (10%) of these patients suffe-
red a recurrence, and 5 patients (25%) had progression 
of the disease during a mean follow-up period of 13 
months (range, 1-45 months). Saito et al.47 reported 
that a gross total removal was achieved in 3 of 6 pa-
tients. An incomplete resection (residual tumors) was 
mainly due to chordoma in the epidural and subdural 
spaces. A recent study of the endoscopic resection of 
cranial base chordomas, published by Koutourousiou 
et al.92, reported an overall rate of gross total of 66.7% 
(82.9% in primary cases and 44% in previously treated 
patients). Important limitations to achieve a gross total 
resection included: a tumor volume greater than 20 cm3 
(p = 0.042), tumor location in the lower clivus with 
lateral extension (p = 0.022), and previously treated 
disease (p = 0.002).
Endoscopic transclival resection of chondrosarco-
mas is often reported in combination with chordoma; 
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thus, their outcomes seem similar. However, their bio-
logical behavior differs significantly. Chordomas tend 
to invade the dura more frequently and have a greater 
propensity for local recurrence. Chondrosarcomas of 
the skull base are typically slow growing lesions that 
most commonly present at the petroclival junction. 
Their behavior correlated with their histological gra-
de. Frank et al.93 reported the extent of extirpation of 
chordomas and chondrosarcomas in 11 patients. Pa-
tient follow-up periods ranged from 15 to 69 months 
(mean, 27 months). Three patients died of chordoma 
progression at 20, 14, and 10 months, respectively, 
after endoscopic treatment. One patient experienced 
two recurrences. They encountered no recurrence in 
2 patients with chondrosarcoma (both had undergone 
a radical resection). Another study reported by Zhang 
et al.94 that they achieved total resection was in 6 pa-
tients of chordoma and 1 case of chondrosarcoma, 
and a subtotal resection in a patient with chordoma 
and another patient with chondrosarcoma. At their last 
follow-up, 7 patients had no evidence of disease and 
1 was alive with disease (a patient with chordoma su-
ffered a recurrence 5 months after a subtotal removal).
Chordomas and chondrosarcomas are rare; thus, 
accruing a significant number of cases is difficult for a 
single institution. Furthermore, outcomes after endos-
copic approaches cannot be directly compared with 
those of the open approaches, as there is a strong 
selection bias. Nonetheless, the outcomes suggest that 
the endoscopic transclival approach is feasible, yields 
an appropriate extent of resection and acceptable on-
cologic outcomes. Furthermore, one should consider 
that advanced chordomas and chondrosarcomas often 
require multi-stage surgery using multiple approaches. 
Their ultimate outcome is also dependent on the ade-
quacy of adjunctive radiation therapy.
Rate and severity of surgical complications is a 
critical consideration when choosing among possible 
surgical approaches. The skull base anatomy is com-
plex and comprises multiple critical neurovascular 
structures. One of the great surgical challenges is the 
avoidance and management of catastrophic bleeding 
(i.e. internal carotid arteries or other major vessel). 
Prevention of injury to the carotid artery is based on 
a proper understanding of skull base anatomy from 
an endoscopic perspective, thorough reviewing of the 
preoperative imaging, use of adjunctive tools such as 
image guidance and acoustic Doppler sonography, and 
cautious dissection. A fundamental tenet is that any 
injury to the ICA must be controlled while maintaining 
cerebral perfusion. Therefore, neurophysiologic moni-
toring is helpful as it reflects cerebral perfusion. Digital 
compression of the cervical carotid may diminish its 
flow, although the effectiveness of this maneuver is 
variable and its logistics not as simple as it appears (the 
two operating surgeons will have their hands occupied 
controlling the bleeding and is difficult to accommodate 
a third person around the head of the patient). Manage-
ment by the anesthesiologist is fundamental and should 
include adequate and prompt resuscitation with fluids 
and blood products. Use of hypotensive anesthesia as 
an attempt to control the bleeding is contraindicated 
since this results in cerebral hypoperfusion.
A key measure that may appear counterintuitive is 
the administration of heparin to avoid embolic pheno-
mena. Ultimately, a two-surgeons-four-hands technique 
with dynamic handling of the endoscope to preserve 
an adequate view of the surgical field and the use of 
two suctions offers the best opportunity to identify and 
control the site of bleeding. Initially the bleeding is 
directed into the suction tips to maintain visualization 
while focal pressure is applied with a cottonoid. The 
endoscope is advanced through the nostril with the least 
blood flow and visualization is maintained by cleaning 
the lens with saline solution (manually or by a lens 
cleansing device)95,96.
Concomitantly, an assistant harvests muscle from 
the thigh (preferred) or abdomen. Some have advoca-
ted harvesting muscle from the temporal area or even 
the tongue; however, this is difficult to do around the 
surgeons that are controlling the bleeding, the volume 
of muscle may be inadequate; and, in the case of the 
tongue, it will be contaminated with oral flora and may 
produce further permanent deficits of speech. The muscle 
is then directly applied over the injury to elicit hemos-
tasis95,96. It should be noted that a muscle patch may 
require 40-45 min to seal the vessel. Once hemostasis 
and resuscitation are successful and the patient vital signs 
and neurophysiologic monitoring are stable, additional 
packing could be placed to hold the muscle in place and 
the patient may be transported to an angiography suite 
for definitive management. Endovascular sacrifice of the 
ICA is the most commonly used alternative; however, 
it is best performed after assessment of collateral blood 
flow with a balloon occlusion test (estimates the risk of 
ischemic stroke and/or the need for bypass).
Using of a covered stent97 may preserve the pa-
tency of the ICA; however, they are not available for intra-
cranial use in all institutions. In addition, deployment of 
a covered stent into the cavernous sinus segment of ICA 
is technically challenging and requires at least 6 weeks 
of antiplatelet therapy. The latter is an important consi-
deration if the tumor needs to be removed or debulked 
urgently. A follow-up angiography is also recommended 
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after any intraoperative vascular injury. These patients are 
at risk for a delayed pseudoaneurysm and rupture that 
can present weeks to years after the event98.
Gardner et al.99 reviewed the incidence of ICA 
injury in 2015 endoscopic skull base surgeries. The 
authors reported an incidence of 0.3% (7 patients); ho-
wever, to include all patients in the denominator for this 
calculation is incorrect. Patients with pathologies of the 
orbit and anterior cranial fossa should have no risk of 
injuring the ICA; thus, the incidence is underestimated 
for patients with pathologies adjacent to any of the 
segments of the ICA. It is interesting to note that most 
of their injuries (5 of 7 patients) involved the left ICA; 
that the most common diagnosis associated with an ICA 
injury was that of a chondroid neoplasm (i.e. chordoma, 
chondrosarcoma; 3 of 7 patients); and that the transclival 
and transpterygoid approaches were associated with a 
higher incidence of injury. The paraclival ICA segment 
was the most commonly injured site (5 of 7 patients. 
A recent verbal communication by the same group 
reported on the use of various maneuvers to stop the 
bleeding including bipolar electro-cauterization of the 
vessel to weld the tear shut or to induce thrombosis of 
the vessel, direct compression, compressive packing, 
suture repair, reconstruction using aneurysm clips, and 
circumferential ligation or clipping of the vessel.
They also advocated attempting the preserva-
tion of lumen by reconstructing the vessel with suture 
repair, aneurysm clips, or using Sundt-Keyes clips. In 
our experience, all these maneuvers require further ex-
posure of the vessel and are associated with significant 
blood loss with a subsequent array of various systemic 
complications. In addition, it is important is to note that 
compressive sinonasal packing is not an option if the 
dura is opened, as blood will track into the subdural 
space. Furthermore, this group also reported a catastro-
phic complication arising from the injection of hemos-
tatic paste into the injury; thus, leading to catastrophic 
embolic phenomena. Skull base surgeons should be 
aware of this possibility and consider ill advised to use 
this technique unless the surgeon is sure that the ICA or 
other major artery is not injured. In our experience, the 
most effective control of an arterial injury is by direct 
control of the injury site using cottonoids followed by 
the direct application of crushed muscle (harvested from 
the abdomen or thigh). Valentine et al. have corrobo-
rated the effectiveness of this maneuver in an elegant 
experimental model95,96.
Despite its dramatic impact a vascular injury is 
not the most common major complication associated 
with endoscopic endonasal skull base surgery. This 
undesirable title belongs to postoperative CSF leak9. Its 
incidence, however, has decreased significantly (< 5%) 
after the adoption of vascularized tissue flaps.
Kassam et al.9 reported other complications 
including transient neurological deficits (2.5%), per-
manent neurological deficits (1.8%), intracranial infec-
tion (1.6%), systemic complications (2.1%) and death 
(0.9%).9 In addition to the potential risk for vascular 
complications, extended endoscopic approaches to 
the infrapetrous region or Meckel’s cave present a 
relatively high risk for other complications including 
injury to CN V or VI. Attentive dissection and the use 
of adjunctive electrophysiologic monitoring help to 
diminish the risk of injury to the cranial nerves. Reduc-
tion of lacrimation (i.e. dry eye) is of concern in the 
postoperative period (especially in patients with CN V
1
 
dysfunction and/or facial paralysis, who cannot protect 
the cornea adequately), and may occur due to injury of 
the sphenopalatine ganglion or vidian nerve. Trismus 
is common after dissection of the pterygoid muscles. 
Analgesics and stretching exercises should be started 
early in the postoperative period to avoid permanent 
and progressive scarring of the muscles that could lead 
to severe limitation of the oral opening.
Pant et al.100 reported sinonasal complications 
that included nasal synechiae (9%), alar sill burn/abra-
sions (5%), maxillary nerve hypoesthesia (2%), palatal 
hypesthesia (7%), incisor hypesthesia (11%), serous 
otitis media (2%), taste disturbance (7%) and malodor 
(19%). These sinonasal complications were frequently 
temporary.
Comparing their experience with endoscopic and 
open resections of the anterior skull base, Eloy et al.56 
reported that the incidence of significant complications 
was greater in the group undergoing an open appro-
ach. In the group of patients undergoing endoscopic 
resect-ion, they encountered three CSF leaks, two 
nose-bleeds, one altered mental status, and one nasal 
stenosis. Conversely, in the group undergoing an open 
approach three patients developed a postoperative CSF 
leak, three patients developed diplopia, one developed 
an epidural hematoma, one suffered a conjunctival tear 
with ipsilateral blindness, one had an ectropion, one 
suffered a wound dehiscence, and one developed sep-
sis. An assessment of postoperative radiological findings 
after anterior craniofacial resection demonstrated that 
more than a third of the patients suffer significant edema 
or contusion and that 75% eventually develop encepha-
lomalacia101. Furthermore, Ganly et al.102,103 surveyed the 
morbidity and mortality of craniofacial resections in a 
collaborative international study, subsequently reporting 
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a complication rate of 36% and a mortality of 5%, and 
that both rates are significantly higher in the elderly 
population.
Quality of life (QOL) is of vital interest for patients 
seeking therapeutic intervention. Several authors have 
demonstrated the quality of life benefits of endoscopic 
endonasal approaches. When compared with open 
approaches, endoscopic approaches cause less postope-
rative pain and discomfort, and are associated to shorter 
operative time and length of hospital stay104. Eloy et al.56 
showed a significant difference in the length of hospital 
stay (mean of 3.8 days for the endoscopic group and 8.1 
days for the open group). Cavel et al.105 evaluated quality 
of life using an anterior skull base surgery questionnaire 
(ASBS-Q). Following endoscopic endonasal resection, 
30 of his 41 patients (75%) reported improvement or 
no change in overall quality of life. Another study by 
McCoul et al.106, assessed the impact of endoscopic 
skull base surgery on both site-specific quality of life, 
using the anterior skull base questionnaire (ASBQ), and 
quality of life related to the sinonasal tract, using the 
Sino-Nasal Outcome Test (SNOT-22). At 3 and 6 weeks 
after surgery, the quality of life by ASBQ was stable 
showing neither a significant decline nor improvement.
However, at 12 weeks postoperatively there 
was significant improvement of quality of life, which 
was maintained at 6 months after surgery (p < 0.05). 
Preoperative quality of life was significantly worse in 
patients who needed revision surgery and it improved 
significantly in the postoperative period in those patients 
who underwent gross-total resection (p < 0.05). Scores 
on the SNOT-22 worsened at 3 weeks postoperatively 
and returned to baseline thereafter. Of note, the use 
of a nasoseptal flap or a presence of a denuded donor 
site did not contribute to a decreased quality of life. 
Bedrosian et al.107 showed a reduction in smell and taste 
at 6 weeks following endoscopic endonasal pituitary 
surgery using a disease-specific quality of life question-
naire. Smell and taste progressively returned to baseline 
at one year. Alobid et al.108, using the Barcelona Smell 
Test (BAST-24), reported similar results, finding that 
patients experienced a reduction in their sense of smell, 
which was more pronounced in those patients who re-
quired expanded approaches. In addition, others have 
studied the influence of using a nasoseptal flap over 
the incidence of postoperative hyposmia and anosmia 
reporting conflicting results100,109,110. This suggests that 
many of these quality of life issues require better defi-
nition with larger scale studies. Therefore, these studies 
suggest that endoscopic skull base surgery is a valuable 
approach for the surgical management of anterior skull 
base pathology, improving site-specific quality of life. 
It is important to recognize that the discussion regar-
ding some of the sinonasal quality of life issues, such 
as crusting, anosmia, and nasal obstruction occurring 
after endoscopic endonasal surgery for malignancies 
needs to consider that similar effects accompany the 
open approaches. Oncologic surgery requires ample 
exposure and a complete ablation with wide margins, 
with inherent destructive consequences; thus, these 
needs trumps mucosal preservation.
Moreover, open approaches seem to be associa-
ted with greater risk of wound seeding than endoscopic 
endonasal approaches. This is an important considera-
tion as it frequently portends a poor prognosis. Moore 
et al.111 estimated that the risk of tumor incisional recur-
rence at 1 year was 3% for all sinonasal malignancies 
and 7% for patients with squamous cell carcinoma. This 
numbers are significant.
Any surgical approach has intrinsic limitations 
that should be considered. Open techniques have diffi-
culty visualizing anatomical structures at deeper and out 
of line-of-sight sites, including the orbital apex, frontal 
recess, and sphenoid sinus, among many others112. 
Rod-lens rigid endoscopy provides magnification, distal 
illumination and visualization (of the surgical target) 
and offers the possibility of angled lenses (0, 30, 45, 70 
degrees) to look around corners and examine structures 
at the deeper levels of the surgical field. Conversely, 
the endoscopic approach only offers a monocular 
view (lacks depth perception); thus, neurosurgeons 
accustomed to binocular visualization need to develop 
compensatory maneuvers. Novel technologies such as 
three-dimensional endoscopes (provide stereoscopic 
vision) and other improvements in endoscopic optics, 
high definition cameras and monitors and will even-
tually eliminate this obstacle. Advantages and caveats 
of three-dimensional endoscopy have been proposed 
in various studies113-117 and its clinical feasibility has 
also been demonstrated118,119. Of note, Felisati et al.120 
reported that surgeons encounter some early difficulties 
that required adaptation (strain, dizziness, difficulties in 
anatomical orientation, and difficulties in performing 
the surgical movements).
Endoscopic approaches seem beneficial and ad-
vantageous in adequately selected patients; however, 
they require specialized technical expertise and signi-
ficant experience. Large and highly invasive tumors, 
such as those with anterior extension to the cranial 
convexity, lateral extension over the orbital roofs and 
those tumors that mandate a total maxillectomy; an 
orbital exenteration or the sacrifice of the facial skin 
should be operated using an open approach (an en-
doscopic approach may be adjunctive). Additionally, 
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an unexpected tumor extension during an endoscopic 
approach may require conversion to an open proce-
dure; thus, a skull base surgery team should be able 
to perform endoscopic, endoscopic assisted and open 
approaches according to the extent of the tumor and 
other patient’s needs.
CONCLUSION
Advanced endoscopic endonasal approaches 
provide an important addition to the surgical 
armamentarium for therapeutic management of the 
skull base malignancies. A critical review of the 
literature shows that it yields satisfactory outcomes and 
limited morbidity; however, these outcomes are highly 
influenced by significant selection biases regarding 
stage, invasiveness, and histopathology of the tumors. 
Therefore, proper selection of cases is critical to the 
achievement of excellent outcomes.
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